Pathological stiffening of the physical microenvironment directly damages epithelial architecture and drives partial epithelial-mesenchymal transition in renal epithelial cells, according to an experimental study published in BMC Nephrology. Chronic kidney disease is characterized by progressive renal fibrosis accompanied by decreased kidney function, where extracellular matrix deposition increases tissue stiffness. In fibrotic disease states, epithelial-mesenchymal transition acts as a key pathological process that compromises tight junction integrity and prompts epithelial cells to acquire mesenchymal phenotypes. This study investigated whether substrate stiffening itself induces epithelial-mesenchymal transition in renal epithelial cells.
To simulate the microenvironmental mechanics of renal tissue, the researchers implemented a tunable polyacrylamide gel system engineered to reproduce distinct physiological and pathological physical states. The cell culture platform compared the mechanical stiffness corresponding to healthy kidneys at 0.9 kilopascals against the elevated stiffness of fibrotic kidney tissue calibrated at 5 kilopascals, alongside conventional rigid glass control surfaces. To assess morphological changes, the localization of the tight junction protein ZO-1, and the expression of EMT-related markers, HEK293A cells were cultured on these substrates.
Culturing HEK293A cells on the stiffer 5 kilopascal substrates and rigid control surfaces triggered marked morphological and structural alterations typical of epithelial-mesenchymal transition. The investigators observed disrupted membrane localization of the essential tight junction protein ZO-1, which compromised structural sealing between adjacent cells and led to increased paracellular permeability across the epithelial monolayer. Alongside these junctional breakdowns, the cells demonstrated a coordinated shift in cellular identity markers, showing substantial upregulation of mesenchymal proteins including alpha-smooth muscle actin, SNAIL1, ZEB1, and vimentin, accompanied by a simultaneous downregulation of the epithelial adhesion molecule E-cadherin.
Investigation of mechanosensitive intracellular signaling pathways revealed that matrix stiffness within the pathophysiological fibrotic range selectively activated the p38 mitogen-activated protein kinase signaling cascade. When researchers introduced pharmacological inhibitors targeted against p38 MAPK, the intervention reduced the expression of alpha-smooth muscle actin and partially restored the continuous membrane localization of ZO-1 in cells exposed to elevated stiffness.
To determine whether these mechanical responses observed in culture correspond to living tissue pathology, the researchers examined in vivo phenotypic alterations in a mouse model of kidney ischemic reperfusion injury. In the fibrotic kidneys of the injured mice, tissue analysis demonstrated increased alpha-smooth muscle actin expression, elevated p38 MAPK activation, and altered ZO-1 localization. These in vivo observations directly paralleled the cellular responses recorded across the tunable gel substrates, confirming that the molecular and morphological changes triggered by substrate stiffening in culture reflect the cellular disruptions occurring in diseased animal tissue.
The authors concluded that scaffold stiffness within the pathophysiological range is a decisive factor governing renal epithelial integrity and the induction of partial epithelial-mesenchymal transition. While traditional cell culture models rely on unyielding rigid substrates that fail to capture native mechanical environments, the tunable polyacrylamide gel system offers a physiologically relevant platform to evaluate renal mechanobiology. Although the investigators noted that further validation across various specialized kidney cell types remains necessary, the experimental findings identify p38 MAPK signaling as an active pathway mediating mechanical fibrosis and suggest that targeting mechanosensitive cascades could offer therapeutic potential in managing chronic renal disease.
Subject of Research: Mechanobiological induction of epithelial-mesenchymal transition by matrix stiffness in renal cells
Article Title: Scaffold stiffening within the pathophysiological range disrupts tight junctions and promotes epithelial mesenchymal transition in renal epithelial cells
Article References: Yokoyama, N., Kushiyama, A., Baba, M., Daikuhara, T., Shimizu, A., Shibauchi, A., Yamamuro, D., & Funaki, M. (2026). Scaffold stiffening within the pathophysiological range disrupts tight junctions and promotes epithelial mesenchymal transition in renal epithelial cells. BMC Nephrology. https://doi.org/10.1186/s12882-026-05483-y
Image Credits: AI Generated
DOI: 10.1186/s12882-026-05483-y
Keywords: renal fibrosis, epithelial-mesenchymal transition, matrix stiffness, chronic kidney disease, tight junctions, ZO-1, p38 MAPK, HEK293A cells, polyacrylamide gel, mechanobiology, alpha-smooth muscle actin, E-cadherin, vimentin, ischemic reperfusion injury, kidney mechanobiology, paracellular permeability
News Source: Ophelia Keating. (November 12, 2026). Substrate Stiffening Drives Partial Epithelial Mesenchymal Transition in Kidney Cells. Scienmag.



